(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Adding a toric platform to a multifocal IOL significantly improves vision at intermediate and near ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...

(RTTNews) - Alcon, a division of Novartis, reported new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens compared to the ZEISS AT ...

Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...

Please provide your email address to receive an email when new articles are posted on . We now have U.S. Food and Drug Administration approval of six presbyopic IOLs: the Advanced Medical Optics ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...